e-learning
resources
Barcelona 2010
Tuesday, 21.09.2010
Pulmonary embolism
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Elevated circulating adiponectin levels in chronic thromboembolic pulmonary hypertension
S. Desole, H. Schrötter, M. Halank, S. Müller, K. Cima, C. M. Kähler (Austria; , Germany)
Source:
Annual Congress 2010 - Pulmonary embolism
Session:
Pulmonary embolism
Session type:
Thematic Poster Session
Number:
4502
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Desole, H. Schrötter, M. Halank, S. Müller, K. Cima, C. M. Kähler (Austria; , Germany). Elevated circulating adiponectin levels in chronic thromboembolic pulmonary hypertension. Eur Respir J 2010; 36: Suppl. 54, 4502
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The definition of pulmonary hypertension: history, practical implications and current controversies
Comparison of acute phase reactant pentraksin-3 and inflammatory parameters in acute and stable pulmonary embolism
Features of patients newly diagnosed pulmonary embolism during COVID pneumonia
Related content which might interest you:
Serum leptin levels in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 259s
Year: 2002
Evaluation of serum cytokines in patients with idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension with hypercholesterolemia
Source: International Congress 2017 – PAH and CTEPH
Year: 2017
Fibrinogen plasma levels and disease severity in pulmonary artery hypertension
Source: Annual Congress 2010 - Pulmonary circulation II
Year: 2010
Plasma metabolomics in chronic thromboembolic pulmonary hypertension
Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension
Year: 2020
The association between pulmonary arterial hypertension secondary to chronic lung disease and serum asymmetric dimethylarginine levels
Source: Annual Congress 2012 - COPD comorbidities II
Year: 2012
P-selectin and PDGF serum levels might not be related to idiopathic pulmonary arterial hypertension and schistosomiasis
Source: Annual Congress 2010 - Pulmonary circulation III
Year: 2010
Changing serum cytokines levels in patients with idiopathic pulmonary arterial hypertension treated with bosentan
Source: Annual Congress 2012 - Clinical management of lung diseases: from bronchi to pleura
Year: 2012
Plasma metabolomics exhibit response to therapy in chronic thromboembolic pulmonary hypertension
Source: Eur Respir J, 57 (4) 2003201; 10.1183/13993003.03201-2020
Year: 2021
Serum levels of microRNA-125a are decreased in patients with precapillary pulmonary hypertension and correlate inversely with hemodynamics
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013
Relationship between circulating thrombomodulin levels and latent progression of atherosclerosis in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous
Year: 2008
Leptin and adiponectin levels in idiopathic pulmonary fibrosis
Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis?
Year: 2011
Exercise dependence of serum NT-PROBNP levels in patients with precapillary pulmonary hypertension
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009
Endothelin-1 and endothelin-3 plasma levels in severe idiopathic pulmonary arterial hypertension
Source: Annual Congress 2005 - Pulmonary hypertension: pathophysiology
Year: 2005
The levels of serum malonyldialhyde and paraoxonase in chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: Suppl. 48, 305s
Year: 2004
Plasma nitrite/nitrate levels: a new biomarker for pulmonary arterial hypertension?
Source: Eur Respir J 2016; 48: 1265-1267
Year: 2016
Elevated levels of adenosine in the lungs lead to chronic lung injury and pulmonary hypertension
Source: Annual Congress 2011 - Experimental pulmonary hypertension
Year: 2011
Serum 1,25(OH)2D levels and arterial hypertension (AH) in sarcoidosis patients
Source: Annual Congress 2009 - Sarcoidosis and profiles of other diffuse parenchymal lung disease
Year: 2009
C-reactive protein and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease with pulmonary arterial hypertension
Source: Annual Congress 2010 - Novel insights into the pathophysiology of asthma and COPD
Year: 2010
Blood MCP-1 levels are increased in chronic obstructive pulmonary disease with prevalent emphysema
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018
Relationship between serum levels of testosterone and the severity of chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – Investigations of COPD
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept